EP. 2: CBD, THC’s Mild-Mannered Kin, is a Risk Worth Watching

Cannabidiol (CBD), a chemical compound from the Cannabid sativa plant, may be less potent than its stony cannabis cousin THC, however CBD might be the far riskier relative. Nearly a dozen major CBD-related class action lawsuits, as well as a handful of legal and regulatory actions against some CBD companies, are pending. All of this bears watching by those in the sector who manage and deal in risk.

Other videos you might like:

• EP. 33 Claims Data on Crime at Cannabis Operations Points Finger at Insiders
• EP.23: Employees May Not Be Working Inside Office Buildings, But Cyber Criminals Are
• EP. 19 : State, Federal Regulatory Enforcement a Focus as Cyber Crime Grows
• EP. 25: Some Insurance Regulators Are Urging Carriers to Insure Cannabis